Eagle Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $91k | 17k | 5.23 |
| 2023-09-30 | $270k | 17k | 15.77 |
| 2023-06-30 | $334k | 17k | 19.44 |
| 2023-03-31 | $899k | 32k | 28.37 |
| 2022-12-31 | $881k | 30k | 29.24 |
| 2022-09-30 | $815k | 31k | 26.42 |
| 2022-06-30 | $1.4M | 31k | 44.44 |
| 2022-03-31 | $1.6M | 33k | 49.51 |
| 2021-12-31 | $1.6M | 32k | 50.93 |
| 2021-09-30 | $1.8M | 33k | 55.78 |
| 2021-06-30 | $1.6M | 37k | 42.80 |
| 2021-03-31 | $1.5M | 36k | 41.73 |
| 2020-12-31 | $1.6M | 35k | 46.57 |
| 2020-09-30 | $1.5M | 35k | 42.49 |
| 2020-06-30 | $1.7M | 34k | 47.97 |
| 2020-03-31 | $1.6M | 35k | 46.01 |
| 2019-12-31 | $2.0M | 34k | 60.08 |
| 2019-09-30 | $1.8M | 32k | 56.56 |
| 2019-06-30 | $1.9M | 33k | 55.68 |
| 2019-03-31 | $1.6M | 32k | 50.50 |
| 2018-12-31 | $1.4M | 34k | 40.29 |
| 2018-09-30 | $1.8M | 27k | 69.33 |
| 2018-06-30 | $1.8M | 24k | 75.65 |
| 2018-03-31 | $1.1M | 20k | 52.69 |
| 2017-12-31 | $1.0M | 20k | 53.43 |
| 2017-09-30 | $1.0M | 17k | 59.62 |
| 2017-06-30 | $1.3M | 16k | 78.89 |
| 2017-03-31 | $1.4M | 17k | 82.92 |
| 2016-12-31 | $987k | 12k | 79.34 |
| 2016-09-30 | $820k | 12k | 70.01 |
| 2016-06-30 | $361k | 9.3k | 38.84 |
| 2016-03-31 | $364k | 9.0k | 40.45 |
| 2015-12-31 | $800k | 9.0k | 88.71 |
| 2015-09-30 | $587k | 7.9k | 74.09 |
| 2015-06-30 | $611k | 7.6k | 80.87 |